Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

The application of hepatitis B virus (HBV)–T‐cell receptor (TCR) T‐cell immunotherapy in patients with HBV‐related hepatocellular carcinoma (HBV‐HCC) has been apathetic, as the expression of HBV antigens by both normal HBV‐infected hepatocytes and HCC cells with HBV‐DNA integration increases the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Anthony Tanoto, Meng, Fanping, Jin, Jiehua, Zhang, Ji‐Yuan, Wang, Si‐Yu, Shi, Lei, Shi, Ming, Li, Yuanyuan, Xie, Yunbo, Liu, Li‐Min, Zhou, Chun‐Bao, Chua, Alicia, Ho, Zi Zong, Luan, Junqing, Zhao, Jinfang, Li, Jing, Wai, Lu‐En, Koh, Sarene, Wang, Tingting, Bertoletti, Antonio, Wang, Fu‐sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948543/
https://www.ncbi.nlm.nih.gov/pubmed/34935312
http://dx.doi.org/10.1002/hep4.1857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948543/
https://www.ncbi.nlm.nih.gov/pubmed/34935312
http://dx.doi.org/10.1002/hep4.1857

Ejemplares similares